Clough Capital Partners’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-83,679
| Closed | -$7.62M | – | 204 |
|
|
2023
Q2 | $7.62M | Buy |
83,679
+55,800
| +200% | +$5.08M | 0.77% | 46 |
|
|
2023
Q1 | $1.84M | Sell |
27,879
-730
| -3% | -$48.2K | 0.2% | 111 |
|
|
2022
Q4 | $1.48M | Sell |
28,609
-14,000
| -33% | -$724K | 0.15% | 116 |
|
|
2022
Q3 | $2.91M | Sell |
42,609
-99,800
| -70% | -$6.82M | 0.31% | 43 |
|
|
2022
Q2 | $6.44M | Hold |
142,409
| – | – | 0.8% | 35 |
|
|
2022
Q1 | $7.24M | Buy |
142,409
+10,660
| +8% | +$542K | 0.55% | 58 |
|
|
2021
Q4 | $6.23M | Sell |
131,749
-6,000
| -4% | -$284K | 0.42% | 59 |
|
|
2021
Q3 | $4.54M | Hold |
137,749
| – | – | 0.28% | 68 |
|
|
2021
Q2 | $8.71M | Sell |
137,749
-351,400
| -72% | -$22.2M | 0.47% | 70 |
|
|
2021
Q1 | $21M | Buy |
489,149
+256,700
| +110% | +$11M | 0.94% | 34 |
|
|
2020
Q4 | $13.3M | Sell |
232,449
-173,385
| -43% | -$9.92M | 0.95% | 43 |
|
|
2020
Q3 | $12.2M | Hold |
405,834
| – | – | 0.88% | 40 |
|
|
2020
Q2 | $13.3M | Hold |
405,834
| – | – | 1.3% | 25 |
|
|
2020
Q1 | $10.9M | Sell |
405,834
-113,000
| -22% | -$3.03M | 1.08% | 29 |
|
|
2019
Q4 | $15.9M | Hold |
518,834
| – | – | 1.36% | 25 |
|
|
2019
Q3 | $12.5M | Sell |
518,834
-73,300
| -12% | -$1.77M | 1.03% | 28 |
|
|
2019
Q2 | $15M | Buy |
592,134
+2,400
| +0.4% | +$60.8K | 1.47% | 21 |
|
|
2019
Q1 | $11.5M | Buy |
589,734
+27,000
| +5% | +$527K | 1.01% | 32 |
|
|
2018
Q4 | $7.42M | Sell |
562,734
-26,382
| -4% | -$348K | 0.87% | 43 |
|
|
2018
Q3 | $10.5M | Buy |
589,116
+11,500
| +2% | +$204K | 0.99% | 30 |
|
|
2018
Q2 | $12.7M | Sell |
577,616
-44,000
| -7% | -$968K | 1.13% | 28 |
|
|
2018
Q1 | $13.7M | Sell |
621,616
-295,500
| -32% | -$6.5M | 1.31% | 22 |
|
|
2017
Q4 | $19.7M | Buy |
+917,116
| New | +$19.7M | 1.64% | 20 |
|